MedPath

Evaluation of efficacy of Double Nasal-Scope Mucosal Cutdown Biopsy using the transnasal endoscope corresponding to the high frequency in gastric submucosal tumor.

Not Applicable
Conditions
Gastric submucosal tumor
Registration Number
JPRN-UMIN000008600
Lead Sponsor
Kanazawa Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

1)At their own request of resignation or withdrawal of informed consent. 2)It was found that patients do not satisfy the criteria after entry. 3)Patients who are judged to be difficult treatment for worsening of the underlying disease. 4)Patients with severe renal failure, liver failure, circulatory failure. 5)Patients who are pregnant, suspected to be pregnant or breastfeeding. 6)Patients with drug allergy and/or history of severe side effects due to analgesic and/or sedatives. 7)Patients who are judged to be difficult treatment for complications. 8)Stop of this study. 9)Patients who are considered to be inapproriate by the investigators.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The rate of confirmed diagnosis by a biopsy.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath